JNJ vs MDT
By Alex · Tickerpine
Johnson & Johnson vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $263.81 | $95.41 |
| Market cap | $635.07B | $122.04B |
| P/E ratio | 40.0 | 23.4 |
| ROE | 20.02% | 10.65% |
| Profit margin | 16.20% | 13.93% |
| Revenue growth | 5.90% | 13.70% |
| Dividend yield | 2.03% | 3.02% |
| Beta | 0.21 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MDT in plain English
- JNJ is the bigger company — about 5.2× the market cap of MDT.
- MDT is cheaper on earnings (P/E 23.4 vs 40.0).
- JNJ earns a higher return on equity (20% vs 11%).
- MDT is growing revenue faster (14% vs 6%).
- MDT has the higher dividend yield (3.02% vs 2.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.